Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166)

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

NCT00102921 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice

NCT03532932 ·Status: COMPLETED

Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease

NCT07078994 ·Status: RECRUITING ·Phase: PHASE2

SC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel Disease

NCT00820365 ·Status: COMPLETED ·Phase: PHASE2

Investigation of Sexual Function in Crohn's Disease Patients With Perianal Fistulas

NCT01635543 ·Status: WITHDRAWN

Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Randomized, Double-arm, Open-label Study

NCT06896305 ·Status: RECRUITING ·Phase: NA

Standardized Fecal Microbiota Transplantation for Crohn's Diseases

NCT01793831 ·Status: RECRUITING ·Phase: NA

A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)

NCT04873700 ·Status: COMPLETED

Prevalence, Characteristics, Management, and Outcomes of Difficult-to-treat Inflammatory Bowel Disease

NCT06551194 ·Status: RECRUITING

IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE

NCT03809728 ·Status: RECRUITING ·Phase: NA

Cytokines and Genes in Therapeutic Response in Crohn's Disease

NCT03266471 ·Status: COMPLETED

Retrospective Data Analysis in Crohn's Disease

NCT01363427 ·Status: COMPLETED

Chronic Diarrhea Owing to Underlying Microscopic Colitis

NCT06530836 ·Status: ACTIVE_NOT_RECRUITING

Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel Diseases

NCT03841045 ·Status: UNKNOWN

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

NCT02958865 ·Status: COMPLETED ·Phase: PHASE2

Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis

NCT07080034 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis

NCT04877990 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

NCT01203631 ·Status: COMPLETED ·Phase: PHASE2

Observational Prospective Study to Identify Intestinal Microbial Profiles in Newly Diagnosed Crohn's Disease Patients

NCT06324591 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Study to Look at Benefit of Surgical Drainage Before Beginning Medical Therapy for Crohns Perianal Fistulas

NCT01145365 ·Status: COMPLETED ·Phase: NA

Study to Evaluate the Epidemiology and the Characteristics "Omics" in Patients Recently Diagnosed of Inflammatory Bowel Disease in Spain

NCT03689257 ·Status: COMPLETED

A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease

NCT07250815 ·Status: COMPLETED

Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143)

NCT01349920 ·Status: COMPLETED

Predictive Factors of ANTI-TNF Response in Luminal Crohn's Disease Complicated by Abscess

NCT02856763 ·Status: COMPLETED

Paricipant Preferences in the Treatment of Inflammatory Bowel Disease (IBD) in Europe

NCT04597905 ·Status: COMPLETED